secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0001493152-22-035162
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX stockholders approve doubling authorized shares to 200M and adding 4M shares to equity plan
--------------------------------------------------------------------------------

- Elected directors Bailey, Hackett, May, West with ~20.4M-20.7M votes each; 5.2M broker non-votes.
- Ratified WithumSmith+Brown as auditor for FY2022: 26.8M for, 31K against.
- Approved amendment to increase authorized common stock from 100M to 200M shares (20.8M for, 1.3M against).
- Approved 2017 Equity Incentive Plan amendment adding 4M shares, total now 8.5M shares available (20.1M for).
- Approved Juvenescence proposal to acquire >19.9% or 50%+ of AGE shares via warrants/loan conversion (20.4M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/0001493152-22-035162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315222035162/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer